Evolus (EOLS) Financials

$9.34 +0.04 (+0.43%)

Closing price 04:00 PM Eastern

Extended Trading

$9.37 +0.03 (+0.32%)

As of 06:42 PM Eastern

Annual Income Statements for Evolus

This table shows Evolus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-50	-62	-74
Consolidated Net Income / (Loss)	-50	-62	-74
Net Income / (Loss) Continuing Operations	-50	-62	-74
Total Pre-Tax Income	-50	-62	-74
Total Operating Income	-34	-49	-65
Total Gross Profit	182	138	90
Total Revenue	266	202	149
Operating Revenue	266	202	149
Total Cost of Revenue	84	65	59
Operating Cost of Revenue	84	65	59
Total Operating Expenses	217	187	155
Selling, General & Admin Expense	198	165	142
Research & Development Expense	9.17	15	6.74
Depreciation Expense	2.34	2.18	0.77
Other Operating Expenses / (Income)	7.18	4.26	-
Total Other Income / (Expense), net	-15	-12	-8.99
Interest Expense	19	14	9.10
Interest & Investment Income	3.26	0.86	0.12
Other Income / (Expense), net	0.13	0.70	-0.01
Income Tax Expense	0.66	0.18	0.10
Basic Earnings per Share	($0.81)	($1.08)	($1.33)
Weighted Average Basic Shares Outstanding	62.02M	56.92M	56.07M
Diluted Earnings per Share	($0.81)	($1.08)	($1.33)
Weighted Average Diluted Shares Outstanding	62.02M	56.92M	56.07M
Weighted Average Basic & Diluted Shares Outstanding	63.59M	57.94M	56.41M

This table shows Evolus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-6.79	-19	-11	-13	-12	-17	-18	-15	-13	-20
Consolidated Net Income / (Loss)	-6.79	-19	-11	-13	-12	-17	-18	-15	-13	-20
Net Income / (Loss) Continuing Operations	-6.79	-19	-11	-13	-12	-17	-18	-15	-13	-20
Total Pre-Tax Income	-6.35	-19	-11	-13	-12	-17	-18	-15	-13	-20
Total Operating Income	-2.31	-15	-7.70	-8.92	-8.64	-13	-15	-12	-11	-18
Total Gross Profit	50	43	48	41	39	35	35	30	27	20
Total Revenue	79	61	67	59	61	50	49	42	44	34
Operating Revenue	79	61	67	59	61	50	49	42	44	34
Total Cost of Revenue	29	18	19	18	22	15	15	12	16	13
Operating Cost of Revenue	29	18	19	18	22	15	15	12	16	13
Total Operating Expenses	53	58	56	50	47	48	50	42	38	38
Selling, General & Admin Expense	50	53	50	45	43	43	41	37	37	35
Research & Development Expense	2.43	2.31	2.35	2.08	6.81	1.59	5.65	1.38	1.35	1.38
Depreciation Expense	-1.58	1.09	1.43	1.41	-1.58	1.31	1.25	1.20	-1.93	0.92
Total Other Income / (Expense), net	-4.04	-3.56	-3.61	-4.14	-3.09	-3.46	-3.00	-2.73	-2.47	-2.37
Interest Expense	4.57	4.76	4.70	4.70	4.08	3.79	3.18	2.79	2.63	2.34
Interest & Investment Income	0.79	0.93	1.03	0.52	0.29	0.31	0.16	0.10	0.08	0.04
Other Income / (Expense), net	-0.25	0.27	0.06	0.05	0.69	0.02	0.02	-0.04	0.08	-0.06
Income Tax Expense	0.44	0.13	0.04	0.05	0.11	0.02	0.02	0.02	0.06	0.01
Basic Earnings per Share	($0.11)	($0.30)	($0.18)	($0.22)	($0.20)	($0.30)	($0.32)	($0.26)	($0.24)	($0.36)
Weighted Average Basic Shares Outstanding	62.02M	63.15M	62.72M	58.80M	56.92M	57.02M	56.92M	56.48M	56.07M	56.18M
Diluted Earnings per Share	($0.11)	($0.30)	($0.18)	($0.22)	($0.20)	($0.30)	($0.32)	($0.26)	($0.24)	($0.36)
Weighted Average Diluted Shares Outstanding	62.02M	63.15M	62.72M	58.80M	56.92M	57.02M	56.92M	56.48M	56.07M	56.18M
Weighted Average Basic & Diluted Shares Outstanding	63.59M	63.32M	63.09M	62.61M	57.94M	57.15M	56.97M	56.92M	56.41M	56.25M

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	24	8.92	-92
Net Cash From Operating Activities	-18	-34	-85
Net Cash From Continuing Operating Activities	-18	-34	-85
Net Income / (Loss) Continuing Operations	-50	-62	-74
Consolidated Net Income / (Loss)	-50	-62	-74
Depreciation Expense	5.30	5.13	3.72
Amortization Expense	1.87	1.85	1.86
Non-Cash Adjustments To Reconcile Net Income	25	17	-2.57
Changes in Operating Assets and Liabilities, net	0.55	3.37	-14
Net Cash From Investing Activities	-4.82	-1.63	-2.94
Net Cash From Continuing Investing Activities	-4.82	-1.63	-2.94
Purchase of Property, Plant & Equipment	-4.82	-1.63	-2.94
Net Cash From Financing Activities	47	45	-4.15
Net Cash From Continuing Financing Activities	47	45	-4.15
Repayment of Debt	0.00	-0.05	-0.50
Repurchase of Common Equity	-0.25	0.00	0.00
Issuance of Debt	0.00	50	0.00
Issuance of Common Equity	51	0.00	0.00
Other Financing Activities, net	-3.55	-5.31	-3.65
Effect of Exchange Rate Changes	-0.48	-0.09	-0.34
Cash Interest Paid	18	13	8.00
Cash Income Taxes Paid	0.24	0.12	0.08

This table details how cash moves in and out of Evolus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	1.92	-8.64	-3.29	34	24	-3.02	10	-22	-12	-19
Net Cash From Operating Activities	4.81	-5.72	-6.47	-11	0.81	-0.92	-13	-21	-8.77	-17
Net Cash From Continuing Operating Activities	4.81	-5.72	-6.47	-11	0.81	-0.92	-13	-21	-8.77	-17
Net Income / (Loss) Continuing Operations	-6.79	-19	-11	-13	-12	-17	-18	-15	-13	-20
Consolidated Net Income / (Loss)	-6.79	-19	-11	-13	-12	-17	-18	-15	-13	-20
Depreciation Expense	1.37	1.09	1.43	1.41	1.37	1.31	1.25	1.20	1.03	0.92
Amortization Expense	0.54	0.47	0.44	0.43	0.42	0.43	0.49	0.51	0.48	0.47
Non-Cash Adjustments To Reconcile Net Income	6.96	6.11	6.37	5.27	8.91	5.61	4.24	-1.43	2.65	3.11
Changes in Operating Assets and Liabilities, net	2.73	5.78	-3.35	-4.61	1.94	8.65	-1.15	-6.07	0.23	-1.27
Net Cash From Investing Activities	-1.36	-1.41	-1.25	-0.80	-0.36	-0.54	-0.22	-0.51	-1.39	-0.90
Net Cash From Continuing Investing Activities	-1.36	-1.41	-1.25	-0.80	-0.36	-0.54	-0.22	-0.51	-1.39	-0.90
Purchase of Property, Plant & Equipment	-1.36	-1.41	-1.25	-0.80	-0.36	-0.54	-0.22	-0.51	-1.39	-0.90
Net Cash From Financing Activities	-1.31	-1.42	4.48	46	24	-1.42	24	-1.28	-1.52	-0.76
Net Cash From Continuing Financing Activities	-1.31	-1.42	4.48	46	24	-1.42	24	-1.28	-1.52	-0.76
Issuance of Common Equity	-3.38	0.59	6.51	47	-0.20	0.06	0.11	0.03	-0.54	0.36
Other Financing Activities, net	2.06	-2.01	-1.78	-1.83	-1.28	-1.48	-1.25	-1.31	-0.48	-1.11
Effect of Exchange Rate Changes	-0.22	-0.09	-0.04	-0.13	0.18	-0.14	-0.05	-0.08	0.03	-0.20
Cash Interest Paid	4.23	4.47	4.41	4.42	3.80	3.52	5.39	0.00	2.35	2.07
Cash Income Taxes Paid	0.04	0.03	0.14	0.03	0.02	0.04	0.03	0.03	0.01	0.02

This table presents Evolus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	233	189	178
Total Current Assets	151	112	101
Cash & Equivalents	87	63	54
Accounts Receivable	48	31	22
Inventories, net	12	11	19
Prepaid Expenses	3.35	5.70	3.90
Other Current Assets	1.20	2.36	1.68
Plant, Property, & Equipment, net	3.22	2.09	2.62
Total Noncurrent Assets	78	74	75
Goodwill	21	21	21
Intangible Assets	49	47	49
Other Noncurrent Operating Assets	8.04	6.17	4.76
Total Liabilities & Shareholders' Equity	233	189	178
Total Liabilities	227	210	159
Total Current Liabilities	63	48	47
Accounts Payable	9.24	4.27	8.94
Accrued Expenses	41	34	25
Other Current Liabilities	13	10	13
Total Noncurrent Liabilities	164	161	113
Long-Term Debt	122	120	72
Noncurrent Deferred & Payable Income Tax Liabilities	0.01	0.03	0.02
Other Noncurrent Operating Liabilities	43	41	41
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5.52	-21	18
Total Preferred & Common Equity	5.52	-21	18
Preferred Stock	0.00	0.00	0.00
Total Common Equity	5.52	-21	18
Common Stock	616	539	516
Retained Earnings	-609	-559	-497
Accumulated Other Comprehensive Income / (Loss)	-0.91	-0.43	-0.34

This table presents Evolus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	230	234	226	168	169	160	193
Total Current Assets	150	158	150	92	96	84	116
Cash & Equivalents	85	94	97	39	42	31	66
Accounts Receivable	45	43	34	30	29	23	21
Inventories, net	15	13	12	18	20	23	22
Prepaid Expenses	3.40	5.51	5.68	3.66	4.30	4.16	3.66
Other Current Assets	2.39	2.43	1.84	1.57	1.60	1.59	4.23
Plant, Property, & Equipment, net	2.31	2.28	2.09	2.13	2.35	2.60	1.88
Total Noncurrent Assets	77	73	74	74	70	74	75
Goodwill	21	21	21	21	21	21	21
Intangible Assets	47	46	47	47	47	48	49
Other Noncurrent Operating Assets	9.14	5.87	6.02	6.13	1.75	4.42	4.58
Total Liabilities & Shareholders' Equity	230	234	226	168	169	160	193
Total Liabilities	224	214	208	187	176	153	163
Total Current Liabilities	61	54	47	49	41	41	51
Accounts Payable	14	10	11	12	7.84	10	8.56
Accrued Expenses	35	33	25	27	24	22	30
Other Current Liabilities	12	11	11	10	9.33	8.38	13
Total Noncurrent Liabilities	163	160	161	139	135	113	112
Long-Term Debt	121	121	121	95	95	72	72
Noncurrent Deferred & Payable Income Tax Liabilities	0.03	0.03	0.03	0.02	0.02	0.02	0.03
Other Noncurrent Operating Liabilities	42	39	40	44	40	41	40
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	5.89	19	18	-19	-6.96	6.95	29
Total Preferred & Common Equity	5.89	19	18	-19	-6.96	6.95	29
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	5.89	19	18	-19	-6.96	6.95	29
Common Stock	609	603	591	528	524	519	514
Retained Earnings	-603	-583	-572	-547	-530	-512	-484
Accumulated Other Comprehensive Income / (Loss)	-0.69	-0.60	-0.56	-0.61	-0.47	-0.42	-0.37

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	31.76%	35.98%	49.10%
EBITDA Growth	34.74%	30.46%	-62.04%
EBIT Growth	29.37%	25.72%	-47.14%
NOPAT Growth	30.11%	24.64%	-47.12%
Net Income Growth	18.26%	17.10%	-58.97%
EPS Growth	25.00%	18.80%	-41.49%
Operating Cash Flow Growth	47.07%	59.95%	-154.32%
Free Cash Flow Firm Growth	21.55%	53.76%	10.82%
Invested Capital Growth	8.81%	1.03%	432.83%
Revenue Q/Q Growth	7.23%	9.39%	6.44%
EBITDA Q/Q Growth	16.85%	6.51%	11.22%
EBIT Q/Q Growth	13.55%	5.11%	10.27%
NOPAT Q/Q Growth	15.52%	3.91%	10.16%
Net Income Q/Q Growth	9.09%	2.12%	6.31%
EPS Q/Q Growth	10.00%	3.57%	13.07%
Operating Cash Flow Q/Q Growth	18.16%	21.99%	0.32%
Free Cash Flow Firm Q/Q Growth	18.50%	7.21%	1.78%
Invested Capital Q/Q Growth	-4.72%	-0.56%	3.10%
Profitability Metrics	-	-	-
Gross Margin	68.46%	68.08%	60.41%
EBITDA Margin	-10.18%	-20.56%	-40.21%
Operating Margin	-12.92%	-24.36%	-43.96%
EBIT Margin	-12.88%	-24.02%	-43.97%
Profit (Net Income) Margin	-18.94%	-30.52%	-50.07%
Tax Burden Percent	101.33%	100.29%	100.13%
Interest Burden Percent	145.13%	126.73%	113.74%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-62.64%	-94.05%	-211.24%
ROIC Less NNEP Spread (ROIC-NNEP)	-119.84%	-166.18%	-110.74%
Return on Net Nonoperating Assets (RNNOA)	727.50%	5,727.38%	62.97%
Return on Equity (ROE)	664.86%	5,633.33%	-148.27%
Cash Return on Invested Capital (CROIC)	-71.08%	-95.07%	-348.03%
Operating Return on Assets (OROA)	-16.27%	-26.45%	-30.01%
Return on Assets (ROA)	-23.92%	-33.62%	-34.18%
Return on Common Equity (ROCE)	664.86%	5,633.33%	-148.27%
Return on Equity Simple (ROE_SIMPLE)	-913.08%	298.15%	-402.25%
Net Operating Profit after Tax (NOPAT)	-24	-34	-46
NOPAT Margin	-9.05%	-17.05%	-30.77%
Net Nonoperating Expense Percent (NNEP)	57.20%	72.13%	-100.50%
Return On Investment Capital (ROIC_SIMPLE)	-18.96%	-34.58%	-50.60%
Cost of Revenue to Revenue	31.54%	31.92%	39.59%
SG&A Expenses to Revenue	74.37%	81.62%	95.44%
R&D to Revenue	3.44%	7.63%	4.54%
Operating Expenses to Revenue	81.39%	92.44%	104.37%
Earnings before Interest and Taxes (EBIT)	-34	-49	-65
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-27	-42	-60
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	126.60	0.00	22.83
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.63	2.98	2.84
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	18.31	17.90	12.08
Enterprise Value to Revenue (EV/Rev)	2.76	3.26	2.96
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	22.00	-5.82	3.89
Long-Term Debt to Equity	22.00	-5.82	3.89
Financial Leverage	-6.07	-34.46	-0.57
Leverage Ratio	-27.80	-167.57	4.34
Compound Leverage Factor	-40.34	-212.36	4.93
Debt to Total Capital	95.65%	120.76%	79.53%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	95.65%	120.76%	79.53%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	4.35%	-20.76%	20.47%
Debt to EBITDA	-4.48	-2.90	-1.20
Net Debt to EBITDA	-1.27	-1.38	-0.30
Long-Term Debt to EBITDA	-4.48	-2.90	-1.20
Debt to NOPAT	-5.04	-3.49	-1.57
Net Debt to NOPAT	-1.43	-1.67	-0.39
Long-Term Debt to NOPAT	-5.04	-3.49	-1.57
Altman Z-Score	-0.71	-1.79	-2.33
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.40	2.33	2.17
Quick Ratio	2.14	1.93	1.64
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-27	-35	-75
Operating Cash Flow to CapEx	-373.19%	-2,090.23%	-2,889.15%
Free Cash Flow to Firm to Interest Expense	-1.46	-2.52	-8.28
Operating Cash Flow to Interest Expense	-0.96	-2.46	-9.33
Operating Cash Flow Less CapEx to Interest Expense	-1.22	-2.58	-9.66
Efficiency Ratios	-	-	-
Asset Turnover	1.26	1.10	0.68
Accounts Receivable Turnover	6.81	7.63	8.01
Inventory Turnover	7.25	4.32	5.71
Fixed Asset Turnover	100.31	85.94	74.55
Accounts Payable Turnover	12.43	9.77	7.83
Days Sales Outstanding (DSO)	53.60	47.84	45.56
Days Inventory Outstanding (DIO)	50.33	84.44	63.93
Days Payable Outstanding (DPO)	29.36	37.36	46.60
Cash Conversion Cycle (CCC)	74.58	94.93	62.90
Capital & Investment Metrics	-	-	-
Invested Capital	40	37	36
Invested Capital Turnover	6.92	5.51	6.86
Increase / (Decrease) in Invested Capital	3.24	0.38	30
Enterprise Value (EV)	734	659	440
Market Capitalization	699	602	422
Book Value per Share	$0.09	($0.36)	$0.33
Tangible Book Value per Share	($1.02)	($1.56)	($0.91)
Total Capital	127	100	90
Total Debt	122	120	72
Total Long-Term Debt	122	120	72
Net Debt	35	58	18
Capital Expenditures (CapEx)	4.82	1.63	2.94
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.43	1.29	0.37
Debt-free Net Working Capital (DFNWC)	88	64	54
Net Working Capital (NWC)	88	64	54
Net Nonoperating Expense (NNE)	26	27	29
Net Nonoperating Obligations (NNO)	35	58	18
Total Depreciation and Amortization (D&A)	7.17	6.98	5.58
Debt-free, Cash-free Net Working Capital to Revenue	0.54%	0.64%	0.25%
Debt-free Net Working Capital to Revenue	33.19%	31.73%	36.53%
Net Working Capital to Revenue	33.19%	31.73%	36.53%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.81)	($1.08)	($1.33)
Adjusted Weighted Average Basic Shares Outstanding	62.02M	56.92M	56.07M
Adjusted Diluted Earnings per Share	($0.81)	($1.08)	($1.33)
Adjusted Weighted Average Diluted Shares Outstanding	62.02M	56.92M	56.07M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	63.59M	57.94M	56.41M
Normalized Net Operating Profit after Tax (NOPAT)	-24	-34	-42
Normalized NOPAT Margin	-9.05%	-17.05%	-28.06%
Pre Tax Income Margin	-18.69%	-30.44%	-50.01%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	-1.83	-3.51	-7.18
NOPAT to Interest Expense	-1.29	-2.49	-5.03
EBIT Less CapEx to Interest Expense	-2.09	-3.63	-7.51
NOPAT Less CapEx to Interest Expense	-1.54	-2.61	-5.35
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.49%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Evolus' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	29.42%	22.12%	35.59%	42.21%	39.76%	47.55%	32.78%	23.04%	25.94%	27.07%
EBITDA Growth	89.32%	-16.81%	56.75%	32.08%	31.98%	29.54%	33.40%	26.38%	45.51%	6.43%
EBIT Growth	67.67%	-13.27%	49.40%	26.50%	24.75%	25.28%	29.35%	21.85%	41.46%	6.02%
NOPAT Growth	73.20%	-15.13%	49.05%	25.90%	18.82%	24.90%	29.18%	22.06%	41.00%	6.35%
Net Income Growth	42.60%	-13.28%	37.43%	11.37%	10.13%	16.54%	22.71%	15.48%	27.58%	-4.34%
EPS Growth	45.00%	0.00%	43.75%	15.38%	16.67%	16.67%	23.81%	16.13%	45.45%	-2.86%
Operating Cash Flow Growth	491.39%	-519.26%	51.39%	48.44%	109.27%	94.58%	36.28%	46.11%	2.99%	46.92%
Free Cash Flow Firm Growth	24.25%	-42.96%	74.62%	96.52%	82.68%	71.07%	58.37%	-7.63%	43.87%	-209.54%
Invested Capital Growth	8.81%	13.56%	0.87%	-11.38%	1.03%	4.75%	36.08%	48.73%	432.83%	269.95%
Revenue Q/Q Growth	29.24%	-8.70%	12.77%	-2.73%	21.95%	1.36%	18.28%	-4.41%	28.75%	-8.78%
EBITDA Q/Q Growth	95.18%	-136.05%	17.96%	-14.50%	47.32%	12.59%	-28.83%	-14.66%	45.43%	17.39%
EBIT Q/Q Growth	83.11%	-98.95%	13.93%	-11.79%	40.82%	11.13%	-25.01%	-14.45%	41.24%	15.97%
NOPAT Q/Q Growth	85.04%	-100.90%	13.67%	-3.32%	35.75%	11.10%	-25.56%	-13.19%	40.57%	16.17%
Net Income Q/Q Growth	64.57%	-68.90%	13.42%	-10.80%	30.09%	6.71%	-22.64%	-12.36%	35.08%	13.61%
EPS Q/Q Growth	63.33%	-66.67%	18.18%	-10.00%	33.33%	6.25%	-23.08%	-8.33%	33.33%	14.29%
Operating Cash Flow Q/Q Growth	184.03%	11.56%	39.05%	-1,405.66%	187.99%	93.06%	35.35%	-134.64%	48.54%	18.37%
Free Cash Flow Firm Q/Q Growth	69.32%	-173.74%	-594.08%	87.00%	42.10%	51.41%	4.92%	35.23%	3.31%	30.08%
Invested Capital Q/Q Growth	-4.72%	-9.66%	10.54%	14.36%	-0.56%	-19.76%	-2.88%	30.38%	3.10%	4.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	63.77%	70.17%	71.49%	69.55%	63.57%	69.15%	70.19%	70.89%	62.60%	60.21%
EBITDA Margin	-0.83%	-22.33%	-8.64%	-11.87%	-10.08%	-23.34%	-27.07%	-24.85%	-20.72%	-48.88%
Operating Margin	-2.93%	-25.33%	-11.51%	-15.04%	-14.16%	-26.87%	-30.64%	-28.86%	-24.37%	-52.80%
EBIT Margin	-3.25%	-24.88%	-11.42%	-14.96%	-13.02%	-26.83%	-30.60%	-28.95%	-24.18%	-52.98%
Profit (Net Income) Margin	-8.60%	-31.38%	-16.96%	-22.09%	-19.40%	-33.83%	-36.76%	-35.45%	-30.16%	-59.81%
Tax Burden Percent	106.93%	100.70%	100.38%	100.36%	100.90%	100.14%	100.13%	100.16%	100.43%	100.06%
Interest Burden Percent	247.41%	125.24%	148.00%	147.14%	147.65%	125.93%	119.99%	122.27%	124.20%	112.83%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-14.21%	-111.32%	-41.24%	-51.59%	-54.65%	-95.98%	-90.31%	-79.51%	-117.11%	-229.76%
ROIC Less NNEP Spread (ROIC-NNEP)	-25.44%	-129.34%	-56.06%	-72.95%	-69.98%	-120.01%	-127.92%	-319.94%	-97.08%	-210.79%
Return on Net Nonoperating Assets (RNNOA)	154.44%	888.44%	-364.83%	-184.62%	2,411.86%	-761.93%	-128.84%	-22.82%	55.20%	136.02%
Return on Equity (ROE)	140.23%	777.12%	-406.07%	-236.21%	2,357.21%	-857.92%	-219.15%	-102.33%	-61.91%	-93.74%
Cash Return on Invested Capital (CROIC)	-71.08%	-84.79%	-59.29%	-59.94%	-95.07%	-103.72%	-127.93%	-148.24%	-348.03%	-341.54%
Operating Return on Assets (OROA)	-4.11%	-31.08%	-13.45%	-17.01%	-14.34%	-27.48%	-27.16%	-23.78%	-16.50%	-36.27%
Return on Assets (ROA)	-10.87%	-39.20%	-19.99%	-25.12%	-21.36%	-34.66%	-32.63%	-29.12%	-20.59%	-40.94%
Return on Common Equity (ROCE)	140.23%	777.12%	-406.07%	-236.21%	2,357.21%	-857.92%	-219.15%	-102.33%	-61.91%	-93.74%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-941.60%	-275.52%	-325.34%	0.00%	325.37%	953.20%	-1,031.83%	0.00%	-271.82%
Net Operating Profit after Tax (NOPAT)	-1.62	-11	-5.39	-6.25	-6.04	-9.41	-11	-8.43	-7.45	-13
NOPAT Margin	-2.05%	-17.73%	-8.06%	-10.53%	-9.91%	-18.81%	-21.45%	-20.20%	-17.06%	-36.96%
Net Nonoperating Expense Percent (NNEP)	11.23%	18.01%	14.83%	21.36%	15.33%	24.03%	37.61%	240.43%	-20.04%	-18.97%
Return On Investment Capital (ROIC_SIMPLE)	-1.28%	-	-	-	-6.06%	-	-	-	-8.24%	-
Cost of Revenue to Revenue	36.23%	29.83%	28.51%	30.45%	36.44%	30.85%	29.81%	29.11%	37.40%	39.79%
SG&A Expenses to Revenue	63.64%	85.96%	74.96%	76.05%	70.59%	86.62%	83.44%	89.60%	84.15%	102.64%
R&D to Revenue	3.08%	3.79%	3.51%	3.50%	11.16%	3.17%	11.45%	3.31%	3.09%	4.06%
Operating Expenses to Revenue	66.70%	95.50%	83.00%	84.59%	77.72%	96.02%	100.82%	99.75%	86.97%	113.00%
Earnings before Interest and Taxes (EBIT)	-2.57	-15	-7.64	-8.88	-7.94	-13	-15	-12	-11	-18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-0.66	-14	-5.78	-7.04	-6.15	-12	-13	-10	-9.04	-17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	126.60	173.54	35.17	43.98	0.00	0.00	0.00	68.68	22.83	15.45
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.63	4.12	2.86	3.69	2.98	2.82	2.45	3.05	2.84	3.23
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	18.31	25.16	15.18	19.82	17.90	15.58	10.12	10.89	12.08	12.94
Enterprise Value to Revenue (EV/Rev)	2.76	4.26	2.98	3.80	3.26	3.12	2.77	3.31	2.96	3.28
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	22.00	20.58	6.26	6.54	-5.82	-4.91	-13.62	10.37	3.89	2.45
Long-Term Debt to Equity	22.00	20.58	6.26	6.54	-5.82	-4.91	-13.62	10.37	3.89	2.45
Financial Leverage	-6.07	-6.87	6.51	2.53	-34.46	6.35	1.01	0.07	-0.57	-0.65
Leverage Ratio	-27.80	-29.50	32.61	15.22	-167.57	36.61	9.52	5.13	4.34	3.22
Compound Leverage Factor	-68.77	-36.94	48.26	22.39	-247.42	46.11	11.43	6.28	5.39	3.64
Debt to Total Capital	95.65%	95.37%	86.23%	86.74%	120.76%	125.58%	107.92%	91.20%	79.53%	71.05%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	95.65%	95.37%	86.23%	86.74%	120.76%	125.58%	107.92%	91.20%	79.53%	71.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	4.35%	4.63%	13.77%	13.26%	-20.76%	-25.58%	-7.92%	8.80%	20.47%	28.95%
Debt to EBITDA	-4.48	-3.72	-3.95	-3.16	-2.90	-2.14	-1.92	-1.29	-1.20	-1.07
Net Debt to EBITDA	-1.27	-1.11	-0.89	-0.62	-1.38	-1.27	-1.08	-0.72	-0.30	-0.09
Long-Term Debt to EBITDA	-4.48	-3.72	-3.95	-3.16	-2.90	-2.14	-1.92	-1.29	-1.20	-1.07
Debt to NOPAT	-5.04	-4.25	-4.46	-3.74	-3.49	-2.65	-2.43	-1.66	-1.57	-1.41
Net Debt to NOPAT	-1.43	-1.27	-1.01	-0.73	-1.67	-1.57	-1.36	-0.94	-0.39	-0.12
Long-Term Debt to NOPAT	-5.04	-4.25	-4.46	-3.74	-3.49	-2.65	-2.43	-1.66	-1.57	-1.41
Altman Z-Score	-0.26	0.40	-0.15	0.19	-1.08	-1.75	-1.89	-1.55	-1.32	-1.04
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.40	2.47	2.92	3.21	2.33	1.90	2.33	2.07	2.17	2.26
Quick Ratio	2.14	2.13	2.53	2.80	1.93	1.42	1.71	1.35	1.64	1.69
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-4.86	-16	-5.79	-0.83	-6.42	-11	-23	-24	-37	-38
Operating Cash Flow to CapEx	353.01%	-405.82%	-515.95%	-1,331.87%	225.21%	-171.43%	-6,162.04%	-4,028.77%	-630.77%	-1,896.66%
Free Cash Flow to Firm to Interest Expense	-1.06	-3.33	-1.23	-0.18	-1.58	-2.93	-7.17	-8.61	-14.09	-16.36
Operating Cash Flow to Interest Expense	1.05	-1.20	-1.38	-2.26	0.20	-0.24	-4.18	-7.38	-3.33	-7.28
Operating Cash Flow Less CapEx to Interest Expense	0.75	-1.50	-1.64	-2.43	0.11	-0.39	-4.25	-7.56	-3.86	-7.66
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.26	1.25	1.18	1.14	1.10	1.02	0.89	0.82	0.68	0.68
Accounts Receivable Turnover	6.81	6.61	6.58	7.62	7.63	7.19	6.74	7.77	8.01	8.16
Inventory Turnover	7.25	4.59	4.32	3.86	4.32	2.84	3.34	4.06	5.71	4.60
Fixed Asset Turnover	100.31	111.76	102.33	93.83	85.94	92.09	88.56	80.26	74.55	94.98
Accounts Payable Turnover	12.43	5.83	7.93	6.31	9.77	5.48	5.86	6.18	7.83	7.33
Days Sales Outstanding (DSO)	53.60	55.20	55.49	47.93	47.84	50.76	54.14	46.96	45.56	44.71
Days Inventory Outstanding (DIO)	50.33	79.51	84.44	94.56	84.44	128.50	109.22	89.99	63.93	79.38
Days Payable Outstanding (DPO)	29.36	62.59	46.02	57.88	37.36	66.64	62.24	59.09	46.60	49.82
Cash Conversion Cycle (CCC)	74.58	72.12	93.91	84.61	94.93	112.63	101.12	77.87	62.90	74.28
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	40	42	47	42	37	37	46	48	36	35
Invested Capital Turnover	6.92	6.28	5.12	4.90	5.51	5.10	4.21	3.94	6.86	6.22
Increase / (Decrease) in Invested Capital	3.24	5.02	0.40	-5.41	0.38	1.68	12	16	30	26
Enterprise Value (EV)	734	1,058	707	835	659	577	467	518	440	458
Market Capitalization	699	1,022	679	811	602	521	414	477	422	452
Book Value per Share	$0.09	$0.09	$0.31	$0.32	($0.36)	($0.34)	($0.12)	$0.12	$0.33	$0.52
Tangible Book Value per Share	($1.02)	($0.98)	($0.77)	($0.85)	($1.56)	($1.53)	($1.32)	($1.10)	($0.91)	($0.73)
Total Capital	127	127	140	139	100	76	88	79	90	101
Total Debt	122	121	121	121	120	95	95	72	72	72
Total Long-Term Debt	122	121	121	121	120	95	95	72	72	72
Net Debt	35	36	27	24	58	56	53	41	18	6.14
Capital Expenditures (CapEx)	1.36	1.41	1.25	0.80	0.36	0.54	0.22	0.51	1.39	0.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)	1.43	4.51	10	6.51	1.29	4.77	13	12	0.37	-0.90
Debt-free Net Working Capital (DFNWC)	88	90	104	103	64	43	55	43	54	65
Net Working Capital (NWC)	88	90	104	103	64	43	55	43	54	65
Net Nonoperating Expense (NNE)	5.17	8.34	5.96	6.86	5.79	7.52	7.56	6.36	5.72	7.75
Net Nonoperating Obligations (NNO)	35	36	27	24	58	56	53	41	18	6.14
Total Depreciation and Amortization (D&A)	1.91	1.56	1.86	1.83	1.79	1.74	1.74	1.71	1.51	1.39
Debt-free, Cash-free Net Working Capital to Revenue	0.54%	1.82%	4.36%	2.96%	0.64%	2.58%	7.95%	7.64%	0.25%	-0.64%
Debt-free Net Working Capital to Revenue	33.19%	36.06%	43.84%	47.09%	31.73%	23.53%	32.69%	27.75%	36.53%	46.32%
Net Working Capital to Revenue	33.19%	36.06%	43.84%	47.09%	31.73%	23.53%	32.69%	27.75%	36.53%	46.32%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.11)	($0.30)	($0.18)	($0.22)	($0.20)	($0.30)	($0.32)	($0.26)	($0.24)	($0.36)
Adjusted Weighted Average Basic Shares Outstanding	62.02M	63.15M	62.72M	58.80M	56.92M	57.02M	56.92M	56.48M	56.07M	56.18M
Adjusted Diluted Earnings per Share	($0.11)	($0.30)	($0.18)	($0.22)	($0.20)	($0.30)	($0.32)	($0.26)	($0.24)	($0.36)
Adjusted Weighted Average Diluted Shares Outstanding	62.02M	63.15M	62.72M	58.80M	56.92M	57.02M	56.92M	56.48M	56.07M	56.18M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	63.59M	63.32M	63.09M	62.61M	57.94M	57.15M	56.97M	56.92M	56.41M	56.25M
Normalized Net Operating Profit after Tax (NOPAT)	-1.62	-11	-4.27	-5.14	-6.04	-8.15	-11	-7.27	-7.45	-12
Normalized NOPAT Margin	-2.05%	-17.73%	-6.38%	-8.66%	-9.91%	-16.29%	-21.45%	-17.44%	-17.06%	-34.45%
Pre Tax Income Margin	-8.04%	-31.16%	-16.90%	-22.01%	-19.22%	-33.79%	-36.71%	-35.40%	-30.03%	-59.78%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-0.56	-3.19	-1.63	-1.89	-1.95	-3.54	-4.75	-4.33	-4.01	-7.67
NOPAT to Interest Expense	-0.35	-2.27	-1.15	-1.33	-1.48	-2.48	-3.33	-3.02	-2.83	-5.35
EBIT Less CapEx to Interest Expense	-0.86	-3.49	-1.89	-2.06	-2.04	-3.69	-4.81	-4.51	-4.54	-8.05
NOPAT Less CapEx to Interest Expense	-0.65	-2.57	-1.42	-1.50	-1.57	-2.63	-3.39	-3.21	-3.36	-5.73
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-0.49%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Evolus' Financials

When does Evolus's fiscal year end?

According to the most recent income statement we have on file, Evolus' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Evolus' net income changed over the last 2 years?

Evolus' net income appears to be on a downward trend, with a most recent value of -$50.42 million in 2024, falling from -$74.41 million in 2022. The previous period was -$61.69 million in 2023. Find out what analysts predict for Evolus in the coming months.

What is Evolus's operating income?

Evolus's total operating income in 2024 was -$34.41 million, based on the following breakdown:

Total Gross Profit: $182.30 million
Total Operating Expenses: $216.72 million

How has Evolus revenue changed over the last 2 years?

Over the last 2 years, Evolus' total revenue changed from $148.62 million in 2022 to $266.27 million in 2024, a change of 79.2%.

How much debt does Evolus have?

Evolus' total liabilities were at $227.05 million at the end of 2024, a 8.3% increase from 2023, and a 42.4% increase since 2022.

How much cash does Evolus have?

In the past 2 years, Evolus' cash and equivalents has ranged from $53.92 million in 2022 to $86.95 million in 2024, and is currently $86.95 million as of their latest financial filing in 2024.

How has Evolus' book value per share changed over the last 2 years?

Over the last 2 years, Evolus' book value per share changed from 0.33 in 2022 to 0.09 in 2024, a change of -73.5%.

Related Companies

This page (NASDAQ:EOLS) was last updated on 5/29/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Evolus (EOLS) Financials

Frequently Asked Questions About Evolus' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Evolus (EOLS) Financials

Annual Income Statements for Evolus

Quarterly Income Statements for Evolus

Annual Cash Flow Statements for Evolus

Quarterly Cash Flow Statements for Evolus

Annual Balance Sheets for Evolus

Quarterly Balance Sheets for Evolus

Annual Metrics And Ratios for Evolus

Quarterly Metrics And Ratios for Evolus

Frequently Asked Questions About Evolus' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools